Sri Lanka - Re-Export of Vaccines for Human Use
Since 2014, Sri Lanka Re-Export of Vaccines for Human Use was up 48.5% year on year. With $459,052.07 in 2019, the country was number 6 among other countries in Re-Export of Vaccines for Human Use. Sri Lanka is overtaken by Kuwait, which was number 5 with $837,476.63 and is followed by Georgia with $363,839.78. United States lead the ranking with $21,386,560.62 in 2019, that is a fall of 18% compared to 2018. United Arab Emirates, Canada and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Guyana recorded the best 5 years average growth at +106.5% per year, while Trinidad and Tobago recorded the worst performance at -49.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 459,052.07 |
| 2018 | 433,292.49 |
| 2017 | 376,276.63 |
| 2016 | 507,306.00 |
| 2015 | 368,226.00 |
Download all data from 2012 to 2019
How does Sri Lanka rank in Re-Export of Vaccines for Human Use?
| # | 22 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
21,386,560.62 | 2019 | -18.0 % | -6.8 % | View data | |
| 2 |
#2
United Arab Emirates
|
7,990,507.15 | 2019 | +36.5 % | +27.7 % | View data | |
| 5 |
#5
Kuwait
|
837,476.63 | 2017 | NA | NA | View data | |
| 6 |
#6
Sri Lanka
|
459,052.07 | 2019 | +6.0 % | +48.5 % | View data | |
| 7 |
#7
Georgia
|
363,839.78 | 2019 | +234.4 % | -23.6 % | View data | |